List of insiders holdings for Passage BIO Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Heron Patrick J Director 10% Owner | 2020-03-03 18:54:26 | 0 5,009,219 | 5,009,219 | Form 4 |
| 2 | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 2023-06-15 10:25:28 | 2,543,698 0 | 2,543,698 | Form 13D |
| 3 | Chou William PRESIDENT AND CEO | 2025-03-18 17:11:39 | 779,533 0 | 779,533 | Form 4 |
| 4 | Lynx1 Capital Management LP Nichols Weston 10% Owner | 2025-09-15 20:05:45 | 0 623,704 | 623,704 | Form 4 |
| 5 | Quigley Jill M. Chief Operating Officer | 2021-12-10 17:30:22 | 400,109 3,608 | 403,717 | Form 4 |
| 6 | Romano Gary Chief Medical Officer | 2021-03-17 21:12:42 | 300,821 0 | 300,821 | Form 4 |
| 7 | Borthwick Kathleen CFO | 2025-03-18 17:12:20 | 278,386 0 | 278,386 | Form 4 |
| 8 | Cale Edgar B. GC & CORPORATE SECRETARY | 2025-03-18 17:11:05 | 278,386 0 | 278,386 | Form 4 |
| 9 | SQUINTO STEPHEN P Head of Research and Dev | 2020-03-02 17:42:09 | 219,612 0 | 219,612 | Form 4 |
| 10 | Forman Mark S CHIEF MEDICAL OFFICER | 2024-03-19 16:09:54 | 203,000 0 | 203,000 | Form 4 |
| 11 | GOWEN MAXINE Director | 2025-05-30 19:31:13 | 201,857 0 | 201,857 | Form 4 |
| 12 | Countouriotis Athena Director | 2025-05-30 19:30:26 | 201,857 0 | 201,857 | Form 4 |
| 13 | Porter Derrell Director | 2025-05-30 19:29:26 | 201,857 0 | 201,857 | Form 4 |
| 14 | Islam Saqib Director | 2025-05-30 19:28:38 | 201,857 0 | 201,857 | Form 4 |
| 15 | Sondhi Dolan Director | 2025-05-30 19:27:46 | 201,857 0 | 201,857 | Form 4 |
| 16 | Kapadia Sandip Director | 2025-05-30 21:41:02 | 201,857 0 | 201,857 | Form 4 |
| 17 | Salinas Eliseo Oreste Chief Res. & Develop Officer | 2022-02-14 17:21:20 | 157,500 0 | 157,500 | Form 4 |
| 18 | Kassberg Thomas Richard Director | 2025-05-30 19:26:39 | 143,789 0 | 143,789 | Form 4 |
| 19 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 2025-07-24 17:44:42 | 132,473 0 | 132,473 | Form 13D |
| 20 | Goldsmith Bruce A CEO and President | 2022-06-01 16:25:24 | 100,000 0 | 100,000 | Form 4 |
| 21 | Fotopoulos Alexandros Chief Technical Officer | 2023-06-20 16:10:44 | 53,693 0 | 53,693 | Form 4 |
| 22 | Burkavage Brian Controller | 2021-06-09 18:30:13 | 30,829 0 | 30,829 | Form 3 |
| 23 | Woiwode Thomas Director 10% Owner | 2023-05-26 16:38:02 | 24,000 0 | 24,000 | Form 4 |
| 24 | King Simona Chief Financial Officer | 2023-08-01 16:36:49 | 23,994 0 | 23,994 | Form 4 |
| 25 | Kamarck Michael E. Director | 2023-05-26 16:31:58 | 21,567 0 | 21,567 | Form 4 |
| 26 | Toernsen Monika Maria Chief Commercial Officer | 2022-11-18 17:01:06 | 18,319 0 | 18,319 | Form 4 |
| 27 | Ratcliffe Liam Director | 2021-05-28 17:58:14 | 16,918 0 | 16,918 | Form 4 |
| 28 | Yamada Tadataka Director | 2021-05-28 18:04:38 | 16,918 0 | 16,918 | Form 4 |
| 29 | Morris Richard Steven Chief Financial Officer | 2021-05-21 18:09:24 | 5,454 0 | 5,454 | Form 4 |
| 30 | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2024-08-09 19:06:55 | 0 0 | 0 | Form 13D |